legislation: 106-hr-5313

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id	congress	bill_type	bill_number	title	policy_area	introduced_date	latest_action_date	latest_action_text	origin_chamber	sponsor_name	sponsor_state	sponsor_party	sponsor_bioguide_id	cosponsor_count	summary_text	update_date	url
106-hr-5313	106	hr	5313	Drug Competition Act of 2000	Commerce	2000-09-27	2000-10-20	Referred to the Subcommittee on Health and Environment.	House	Rep. Andrews, Robert E. [D-NJ-1]	NJ	D	A000210	0	Drug Competition Act of 2000 - Requires brand name drug manufacturers and generic drug manufacturers to notify the Federal Trade Commission and the Attorney General of agreements regarding the sale or manufacture of generic drugs which could have the effect of limiting the research, development, manufacture, marketing, or selling of a generic drug product.	2025-08-20T14:20:48Z

Links from other tables

6 rows from bill_id in legislation_actions
19 rows from bill_id in legislation_subjects
0 rows from bill_id in legislation_cosponsors
0 rows from bill_id in cbo_cost_estimates